SCHEMBL23901540

SCHEMBL23901540

CNC(CCC(=O)OC(C)(C)C)C(N)=O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 4/20 0.33
CYP2D6 P10635 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 2/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
P2RY12 Q9H244 4/20 0.32
POLB P06746 1/20 0.31
EPHX2 P34913 1/20 0.31
CTSS P25774 1/20 0.31
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13711118 1.00 CTSK (0.33) CTSKCYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL13711116 0.90 CTSK (0.38) CTSKCYP2D6KMT2AHDAC3HDAC1
SCHEMBL17178074 0.88 CYP2D6 (0.34) CTSKCYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL19541637 0.85 P2RY12 (0.33) CTSKCYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL13876903 0.84 MEN1 (0.40) CTSKCYP2D6KMT2AHDAC3HDAC1
SCHEMBL18575864 0.84 MEN1 (0.40) CTSKCYP2D6KMT2AHDAC3HDAC1
SCHEMBL9086263 0.84 L3MBTL1 (0.37) CTSKCYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL13707885 0.83 CTSK (0.40) CTSKCYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL14539748 0.83 CTSK (0.47) CTSKCYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL23901491 0.83 CTSK (0.40) CTSKCYP2D6CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021202600-A1 SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ THE SCRIPPS RESEARCH INSTITUTE (US) 2021-10-07 WO disclosed